April 02, 2019 article Open access Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis Annals of the Rheumatic Diseases DOI: 10.1136/annrheumdis-2018-214764 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 2 stored of 69 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Conceptual framework for the definition of disease modification in systemic sclerosis and potential implications for drug development and clinical study design 2026 Annals of the Rheumatic Diseases article Medicine Systemic Sclerosis and Related Diseases Open access 0 citations Prediction of damage trajectories in systemic sclerosis using group-based trajectory modelling 2023 Lara D. Veeken article Medicine Systemic Sclerosis and Related Diseases Open access 5 citations 2 results References 0